Because serum levels of IL-6 and sIL-6R, but not spg130, are increased in PAH patients, it is thought that IL-6 trans-signaling may be involved in PAH pathogenesis (Jasiewicz et al., 2015). Here, IL6R is linked to pulmonary arterial hypertension.